The outlook for drug development to treat rare diseases looks encouraging, offering hope to the 300 million people globally facing the significant challenges of these often-overlooked conditions.

Despite significant R&D investments, pharma companies often underestimate the multifaceted challenges of bringing promising treatments to market – from securing favourable reimbursement to developing ...

A revolution in novel nanoparticles and colloidal building blocks has been enabled by recent breakthroughs in particle synthesis. These new particles are poised to become the ‘atoms’ and ‘molecules’ ...

Complex networks are networks that feature patterns of connection between their elements that are neither purely regular nor purely random. Most real-world networks, such as transportation, social or ...